Phosphorus

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Phosphorus is a medication indicated in the treatment of hypophosphatemia.

Generic Name
Phosphorus
DrugBank Accession Number
DB14151
Background

Not Available

Type
Small Molecule
Groups
Approved, Experimental
Structure
Weight
Average: 30.9738
Monoisotopic: 30.973761512
Chemical Formula
P
Synonyms
  • Phosphorous
  • Phosphorus, elemental

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to preventBone lossCombination Product in combination with: Cholecalciferol (DB00169), Calcium (DB01373)••• ••••••••••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Advanced B & T FormulaPhosphorus (100 mg) + Ascorbic acid (33.3 mg) + Calcium (200 mg) + Chromium (33.33 mcg) + Copper (0.5 mg) + Cyanocobalamin (6.67 mcg) + Folic acid (0.133 mg) + Iron (1.67 mg) + Magnesium (83.3 mg) + Manganese (3.33 mg) + Nicotinamide (6.67 mg) + Calcium pantothenate (5 mg) + Potassium (16.67 mg) + Pyridoxine hydrochloride (6.67 mg) + Riboflavin (2.67 mg) + Selenium (33.33 mcg) + Silicon (0.333 mg) + Sodium molybdate (16.67 mcg) + Thiamine (2.67 mg) + Vanadium (8.33 mg) + Vitamin D (66.67 unit) + Zinc (5 mg)CapsuleOralNutraceutical CorporationNot applicableNot applicableCanada flag
Anaplex TabPhosphorus (75.33 mg / tab) + Ascorbic acid (40 mg / tab) + Calcium (160 mg / tab) + Iodine (.05 mg / tab) + Magnesium oxide (50 mg / tab) + Nicotinamide (30 mg / tab) + Calcium pantothenate (15 mg / tab) + Potassium chloride (20 mg / tab) + Pyridoxine hydrochloride (40 mg / tab) + Vitamin A palmitate (2000 unit / tab) + Vitamin D (133.33 unit / tab)TabletOralAnabolic Laboratories Inc.1975-12-311996-10-02Canada flag
Calci A and D TabPhosphorus (70 mg) + Calcium (165 mg) + Vitamin A (1000 unit) + Vitamin D (100 unit)TabletOralPharmetics (2011) Inc.1981-12-312006-07-27Canada flag
Calcium Phosphorus & Vitamin DPhosphorus (97 mg / tab) + Calcium (215 mg / tab) + Vitamin D (100 unit / tab)TabletOralAvacare, Division Of Jeunique International Inc.1985-12-311996-09-09Canada flag
Chelamins Plus TabPhosphorus (75 mg) + Calcium (350 mg) + Chromium (50 mcg) + Copper (1.5 mg) + Iodine (.15 mg) + Iron (15 mg) + Magnesium (175 mg) + Manganese (5 mg) + Potassium (47.5 mg) + Selenium (25 mcg) + Vitamin D (200 unit) + Zinc (11.25 mg)TabletOralNu Life Nutrition Ltd.1988-12-312000-03-03Canada flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
27YLU75U4W
CAS number
7723-14-0
InChI Key
OAICVXFJPJFONN-UHFFFAOYSA-N
InChI
InChI=1S/P
IUPAC Name
phosphorus
SMILES
[P]

References

General References
  1. TITCK: Megadyn Pronatal (Multivitamin) Oral Tablet [Link]
Human Metabolome Database
HMDB0001315
ChemSpider
4575369
RxNav
8263
ChEBI
30207
Wikipedia
Phosphorus

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4RecruitingTreatmentX-Linked Hypophosphatemia1
3Unknown StatusTreatmentChronic Kidney Disease (CKD)1
2, 3CompletedTreatmentOverweight / Pregnancy / Psychiatric Disorder NOS1
1, 2CompletedTreatmentDent's Disease1
Not AvailableCompletedNot AvailableChronic Kidney Disease (CKD)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, film coatedOral
Tablet
Capsule
TabletOral
LiquidOral
CapsuleOral
Capsule, gelatin coatedOral
PowderOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0.3Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count0Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area0 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity5.2 m3·mol-1Chemaxon
Polarizability1.78 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-001i-9000000000-88317f9b56fea79262a0
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-b25ebf44fa1deb41a771
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-b25ebf44fa1deb41a771
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-b25ebf44fa1deb41a771
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-108.291565
predicted
DeepCCS 1.0 (2019)
[M+H]+110.04523
predicted
DeepCCS 1.0 (2019)
[M+Na]+116.777725
predicted
DeepCCS 1.0 (2019)

Drug created at June 28, 2018 19:42 / Updated at May 14, 2021 01:06